RSV in infants: new study aims to unlock asthma mystery
NCT ID NCT07653347
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 300 infants to understand how catching RSV very early (before 4 months old) versus later (after 6-9 months) affects their immune system and long-term health. Researchers will measure antibody responses and track asthma-like symptoms. The goal is to learn why early RSV infection is linked to more severe illness and higher asthma risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help explain why some infants develop asthma after RSV and guide future prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any drug or vaccine, so it cannot provide immediate health benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA CHILDHOOD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BC Women's Hospital and Health Centre
RECRUITINGVancouver, British Columbia, V6H 3N1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study: exercise classes may help kids control asthma
- Can a home breathing program help kids with asthma breathe easier?
- Tailored diet plans during pregnancy show promise in cutting preterm birth and diabetes risk
- Smart spacer could help kids breathe easier
- New asthma attack protocol for kids: will standardizing care reduce ER visits?
- Tiny noses, big clues: study hopes nose bugs predict preterm lung disease